2021 - Lung function trajectories from birth to death, health and disease, and pre-war to today

CADSET is a pan-European network committed to promoting clinical research in chronic airway diseases. The overarching working hypothesis of CADSET is that Asthma and Chronic Obstructive Pulmonary Disease (COPD) represent a continuum of heterogeneous chronic airway diseases that share clinical, functional, imaging and/or biological mechanisms (i.e endotypes), that can be identified by appropriately validated biomarkers, which may constitute novel therapeutic targets.

Multi-level (clinical, functional, imaging and molecular) profiling of well-characterized patients with chronic airways disease, spanning the spectrum of asthma and COPD, that considers both peak lung function achieved in early adulthood and the rate of lung function decline, may lead to the identification of distinct endotypes (and appropriate biomarkers) which may, in turn, inform a mechanism-based disease classification and a more personalized treatment of patients with chronic airways diseases.

2021 - Lung function trajectories from birth to death, health and disease, and pre-war to today

2023 - In Vitro Diagnostic (IVD) tests to combat antimicrobial resistance in community-acquired low-respiratory tract infections (CA-LRTI)

2024 - Sleep apnea and its consequences: from animal models to precision medicine

2019 - New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine

Welcome and introduction

R. Faner (Barcelona, Spain), G. Donaldson (London, United Kingdom)

Assembly Symposium

Replay

Slides

Early, Mild, Young and Old COPD, where do we stand?

A. Agusti (Barcelona, Spain)

Replay

Slides

Accompanying documents

Asthma, COPD and ACOS - are they different?

I. Pavord (Oxford, United Kingdom)

Replay

Slides

Accompanying documents

Why does chronic bronchitis and lung infection accelerate lung function decline

J. Wedzicha (London, United Kingdom)

Replay

Slides

Session 1: The meaning of the words - General discussion

Assembly Symposium

Replay

What is the latest research on the influence of cigarette smoking, vaping and atmospheric pollution on lung function decline

M. Boezen (Groningen, Netherlands)

Replay

Slides

Accompanying documents

Physical activity and lung function along the lifecourse

J. Garcia Aymerich (Barcelona, Spain)

Replay

Slides

Accompanying documents

Pharmacological and Non-pharmacological therapies that modulare lung function decline

P. Calverley (Liverpool, United Kingdom)

Replay

Slides

Accompanying documents

Session 2: State of the art and beyond - General discussion

Assembly Symposium

Replay

Epidemiological issues with investigating lung function trajectories

D. Jarvis (London, United Kingdom)

Assembly Symposium

Replay

Slides

Accompanying documents

Pre- and post-natal influences on lung development during childhood

E. Melén (Stockholm, Sweden)

Replay

Slides

Accompanying documents

The development of equations to describe normal values: the past and current insights from the GLI project

S. Stanojevic (Toronto, Canada)

Replay

Slides

Accompanying documents

Session 3: Lung function across the Life Course - General discussion

Assembly Symposium

Replay

Lung function trajectory research: historical perspective and future prospects

L. Fabbri (Modena, Italy)

Replay

Slides

Accompanying documents

Conclusion - General discussion

Assembly Symposium

Replay

2021 - Lung function trajectories from birth to death, health and disease, and pre-war to today

2021 - Lung function trajectories from birth to death, health and disease, and pre-war to today

#{title}